The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria

OBJECTIVES: To investigate the necessity of stratifying patients in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center (MSKCC) criteria in a real-world population of patients with metastatic renal cell carcinoma. PATIENTS AND METHODS: We retrospectively analyzed 234 consecutiv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Tamada, Satoshi, Iguchi, Taro, Yasuda, Sayaka, Kato, Minoru, Yamasaki, Takeshi, Nakatani, Tatsuya
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021254/
https://ncbi.nlm.nih.gov/pubmed/29963234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25554
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky